Patent foramen ovale medical therapy: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

(newest | oldest) View ( | older 250) (20 | 50 | 100 | 250 | 500)

8 January 2013

7 January 2013

4 January 2013

2 November 2012

  • curprev 17:2717:27, 2 November 2012WikiBot talk contribsm 9,899 bytes +3 Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...

1 November 2012

11 October 2012

30 August 2012

4 November 2011

10 September 2011

  • curprev 22:4222:42, 10 September 2011Priyamvada Singh talk contribs 9,813 bytes +57 /* American Academy of Chest Physicians Guidelines for prevention of recurrent cerebral embolism in patent foramen ovale (DO NOT EDIT) {{cite journal| author=Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P| title=Antithrombotic and thrombolytic th
  • curprev 22:3922:39, 10 September 2011Priyamvada Singh talk contribs 9,756 bytes +165 /* American Academy of Chest Physicians Guidelines for prevention of recurrent cerebral embolism in patent foramen ovale (DO NOT EDIT) {{cite journal| author=Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P| title=Antithrombotic and thrombolytic th

9 September 2011

8 September 2011

6 September 2011

5 September 2011

4 September 2011

(newest | oldest) View ( | older 250) (20 | 50 | 100 | 250 | 500)